Guardian Pharmacy Services (GRDN): Director bought ~$500K
Thomas J Jr Salentine, Director at Guardian Pharmacy Services, bought ~$500K of Guardian Pharmacy Services shares.
- ~$500K
- Approx. value · 36K sh @ $14.00
- 36K
- Holds after · shares reported
- Traded
- Sep 27, 2024
- Filed
- Oct 1, 2024
What stands out in this filing
- After this purchase the filing reports 35,714 shares.
- 35,714 shares at an average of $14.00 each, as reported on the form.
- 3 other insiders at GRDN also bought in the open market within 30 days.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 27, 2024 · this disclosureInsiderDirector purchased ~$500K of GRDN shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Guardian Pharmacy Services
For Guardian Pharmacy Services, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GRDN page.
Other recent filings by Thomas J Jr Salentine, Director
- SEC Form 4 at Guardian Pharmacy Services (GRDN)May 29, 2025
- SEC Form 4 at Guardian Pharmacy Services (GRDN)May 29, 2025
The full history of Thomas J Jr Salentine, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Guardian Pharmacy Services (GRDN) insider traded, and how much?
Thomas J Jr Salentine, Director at Guardian Pharmacy Services, bought ~$500K of Guardian Pharmacy Services shares. 36K shares at $14.00, open market.
When did it happen, and when was it made public?
Traded: Sep 27, 2024. Filed: Oct 1, 2024. That is 4 days between the two dates.
What stands out in this filing?
After this purchase the filing reports 35,714 shares. 35,714 shares at an average of $14.00 each, as reported on the form. 3 other insiders at GRDN also bought in the open market within 30 days.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Guardian Pharmacy Services recently?
For Guardian Pharmacy Services, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the GRDN page.
Does this mean GRDN stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Guardian Pharmacy Services
- SEC Form 4Nov 19, 2026
- SEC Form 4Nov 19, 2026
- SEC Form 144Nov 17, 2026
- SEC Form 4Sep 30, 2025
- SEC Form 4Sep 30, 2025
- SEC Form 4Sep 30, 2025
Everything OQRO holds on this company is on its GRDN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
